SIGN UP
LOG IN
News
China Shineway Pharmaceutical Group
--
--
0.00%
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0428-0502)?
Weekly Report · 6d ago
China Shineway Pharmaceutical Group (HKG:2877) Has Announced A Dividend Of CN¥0.385
Simply Wall St · 04/29 06:36
China Shineway Pharmaceutical Group Full Year 2024 Earnings: Misses Expectations
Simply Wall St · 04/28 01:56
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0421-0425)?
Weekly Report · 04/27 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0414-0418)?
Weekly Report · 04/20 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0407-0411)?
Weekly Report · 04/13 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0331-0404)?
Weekly Report · 04/06 22:01
China Shineway Pharmaceutical Group (HKG:2877) Will Pay A Dividend Of CN¥0.385
Simply Wall St · 04/01 01:23
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0324-0328)?
Weekly Report · 03/30 22:01
CHINA SHINEWAY PHARMACEUTICAL GROUP FY SALES RMB 3,780 MILLION
Reuters · 03/28 04:01
China Shineway Pharmaceutical Group's (HKG:2877) five-year total shareholder returns outpace the underlying earnings growth
Simply Wall St · 03/25 22:53
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0317-0321)?
Weekly Report · 03/23 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0310-0314)?
Weekly Report · 03/16 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0303-0307)?
Weekly Report · 03/09 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0224-0228)?
Weekly Report · 03/02 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0217-0221)?
Weekly Report · 02/23 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0210-0214)?
Weekly Report · 02/16 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0203-0207)?
Weekly Report · 02/09 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0127-0131)?
Weekly Report · 02/02 22:01
Weekly Report: what happened at China Shineway Pharmaceutical Group last week (0120-0124)?
Weekly Report · 01/26 22:01
About China Shineway Pharmaceutical Group
China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.
MoreRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.